| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2011 | WO2010124283A3 Methods and compositions relating to hematologic malignancies |
| 03/03/2011 | WO2010123838A3 Novel amide and amidine derivatives and uses thereof |
| 03/03/2011 | WO2010123648A3 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction |
| 03/03/2011 | WO2010120489A3 Drug delivery system and methods of use |
| 03/03/2011 | WO2010118347A3 O-linked glycan biosynthesis modulators |
| 03/03/2011 | WO2010117727A3 Phenserine and posiphen for treating neuropsychiatric and neurodegenerative conditions |
| 03/03/2011 | WO2010117233A3 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same |
| 03/03/2011 | WO2010117199A3 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles |
| 03/03/2011 | WO2010108077A3 Controlled release particulates containing water-insoluble drug |
| 03/03/2011 | WO2010102991A3 Riluzole liquid emulsions |
| 03/03/2011 | WO2010102923A3 Riluzole aqueous suspensions |
| 03/03/2011 | WO2010091241A3 Compositions and methods for promoting the generation of definitive endoderm |
| 03/03/2011 | WO2010085699A3 Mammalian piggybac transposon and methods of use |
| 03/03/2011 | WO2010046931A3 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof |
| 03/03/2011 | WO2010036998A3 Indole and indoline derivatives and methods of use thereof |
| 03/03/2011 | WO2010028216A8 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 03/03/2011 | WO2010002779A3 Naphthyridininones as aurora kinase inhibitors |
| 03/03/2011 | WO2009158032A9 Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
| 03/03/2011 | WO2008139264A3 Soft gel formulations |
| 03/03/2011 | WO2008129358A3 Oil producing microbes and methods of modification thereof |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | WO2008038155A3 Controlled-release pharmaceutical tablets |
| 03/03/2011 | WO2008035209A3 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
| 03/03/2011 | WO2008035208A3 The use of polymethoxyflavones for the non apoptotic inhibition of cancer cell growth |
| 03/03/2011 | WO2008023273A3 Method for improving pharmacokinetics |
| 03/03/2011 | WO2007054776A9 Stilbene like compounds as novel hdac inhibitors |
| 03/03/2011 | US20110055943 Novel therapeutic targets in inflammatory bowel disease |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054375 Dressing comprising polyacrylate particles and use thereof |
| 03/03/2011 | US20110054347 Devices for Selective Recruitment, Isolation, Activation, and/or Elimination of Various Cell Populations |
| 03/03/2011 | US20110054159 Rna interference mediating small rna molecules |
| 03/03/2011 | US20110054153 Method of purifying apo-2 ligand/trail usin crystallisation the cold |
| 03/03/2011 | US20110054042 Polymer compositions |
| 03/03/2011 | US20110054040 Bicyclic Triterpenoid Iripallidal as a Novel Anti-Glioma and Anti-Neoplastic Therapy |
| 03/03/2011 | US20110054039 Use of alkyl sulfates or sulfonates against propionibacterium acnes |
| 03/03/2011 | US20110054038 Cns pharmaceutical compositions and methods of use |
| 03/03/2011 | US20110054037 Bis-aromatic anticancer agents |
| 03/03/2011 | US20110054036 Composition and method for irrigation of a prepared dental root canal |
| 03/03/2011 | US20110054035 Combination Comprising Combretastatin and Anticancer Agents |
| 03/03/2011 | US20110054034 Methods of using carboxylic amides as antimicrobial agents |
| 03/03/2011 | US20110054033 Methods of using abscisic acid for ameliorating hypertension and vascular inflammation |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054031 Ophthalmic NSAIDS as Adjuvants |
| 03/03/2011 | US20110054030 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 03/03/2011 | US20110054029 Water-soluble dietary fatty acids |
| 03/03/2011 | US20110054028 Supplement for reducing hiv transmission and method thereof |
| 03/03/2011 | US20110054025 Use of a pentacyclic triterpene in a pharmaceutical composition for the treatment of multiple sclerosis |
| 03/03/2011 | US20110054023 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses |
| 03/03/2011 | US20110054021 Calcilytic Compounds |
| 03/03/2011 | US20110054020 Napthylene inhibitors of cyclooxygenase |
| 03/03/2011 | US20110054019 Cancer Starvation Therapy |
| 03/03/2011 | US20110054018 Inotilone derivatives as coherent biological response modifier (cBMR) |
| 03/03/2011 | US20110054017 Substituted furans and their use |
| 03/03/2011 | US20110054016 Method for modulating claudin mediated functions |
| 03/03/2011 | US20110054015 Solid forms of ortataxel |
| 03/03/2011 | US20110054014 Prenylflavanone compounds and uses thereof |
| 03/03/2011 | US20110054013 Tetrahydropyranochromene gamma secretase inhibitors |
| 03/03/2011 | US20110054012 Methods and Compositions for Increasing Gene Expression |
| 03/03/2011 | US20110054011 RNA Antagonist Compounds for the Modulation of FABP4/AP2 |
| 03/03/2011 | US20110054010 Transcription Factor Decoys And Use Thereof |
| 03/03/2011 | US20110054009 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders |
| 03/03/2011 | US20110054008 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma |
| 03/03/2011 | US20110054006 Regulation of oncogenes by micrornas |
| 03/03/2011 | US20110054005 Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same |
| 03/03/2011 | US20110054004 Method for reducing scarring during wound healing using antisense compounds directed to ctgf |
| 03/03/2011 | US20110054003 Antisense oligonucleotide modulation of stat3 expression |
| 03/03/2011 | US20110054002 Alkyl indole-3-carbinol-derived antitumor agents |
| 03/03/2011 | US20110054001 Chk1 suppresses a caspase-2 apoptotic response to dna damage that bypasses p53, bcl-2 and caspase-3 |
| 03/03/2011 | US20110053999 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| 03/03/2011 | US20110053998 Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties |
| 03/03/2011 | US20110053997 Salts and Crystal Forms |
| 03/03/2011 | US20110053995 Benzenesulfonanilide compound inhibitors of urea transporters |
| 03/03/2011 | US20110053994 Potent immunosuppressive agents, derivatives and uses |
| 03/03/2011 | US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/03/2011 | US20110053992 Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS) |
| 03/03/2011 | US20110053991 Treatment of Histone Deacetylase Mediated Disorders |
| 03/03/2011 | US20110053990 Fatty acid niacin conjugates and their uses |
| 03/03/2011 | US20110053989 Methods and materials for treating orthostatic hypotension or postural tachycardia syndrome |
| 03/03/2011 | US20110053988 Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke |
| 03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same |
| 03/03/2011 | US20110053986 Respiratory disease treatment |
| 03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053984 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053981 Methods and Compositions Using Cholinesterase Inhibitors |
| 03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
| 03/03/2011 | US20110053979 Pyridine derivatives used to treat orexin related disorders |
| 03/03/2011 | US20110053978 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 03/03/2011 | US20110053977 Small molecule e2f inhibitor |
| 03/03/2011 | US20110053976 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 03/03/2011 | US20110053975 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053972 Inhibitors of akt activity |
| 03/03/2011 | US20110053971 Nalmefene di-ester prodrugs |
| 03/03/2011 | US20110053970 Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency |
| 03/03/2011 | US20110053969 Novel diazasipiroakanes and their use for treatment of ccr8 mediated diseases |
| 03/03/2011 | US20110053968 Aminopyrimidine inhibitors of tyrosine kinase |
| 03/03/2011 | US20110053967 (poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents |